This has potentially important implications in clinical practice. A recent report from Italy suggests that the prevalence of arterial hypertension is significantly higher amongst COVID-19 patients admitted to ICU who do not survive. 7 Our study has several limitations related to the observational nature of the studies reviewed with all inherent biases. Few investigations have examined the link between arterial hypertension and ICU admission in COVID-19 patients, limiting the number of the studies included in the metaanalysis. No formal definition of arterial hypertension was given in the included studies. The need for ICU admission may have depended on local resources that are often different between units. No adjustments for confounders were made for other risk factors such as age or other baseline cardiovascular or chronic comorbidities. All included studies were performed in China, so we cannot exclude significant differences between other populations. Because we considered only published studies in English, we cannot exclude missing some investigations with interesting findings published only in Chinese in particular. In our analysis, the degree of increased risk of ICU admission in hypertensive patients was strongly influenced by a single study, that of Guan and colleagues. 2 The identification of those predictors indicating a need for intensive care admission could be helpful in managing the early phase of the pandemic both for clinical and ICU management. However, our results should be considered preliminary, and further research is necessary to confirm our findings. 8 Declarations of interest The authors declare that they have no conflicts of interest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.